cross-posted from : https://lemmy.zip/post/66691506
China has become a major source of new medicines and clinical research, reshaping the global pharmaceutical-industry landscape, Pfizer Chief International Commercial Officer Alexandre de Germay said at an event hosted by industry lobby group the European Federation of Pharmaceutical Industries and Associations (EFPIA).
“Today, 40% of all clinical studies in oncology in the world are in China,” de Germay said. “The volume of innovation that is coming out of biotech in China is just amazing.”
Not surprising. An epi pen in the US costs 600$. Pharma is the epitome of greed.
the brand name company is owned by MANCHINS DAUGHTER i believe, she was behind the sudden increase. i think the generics are sitll cheap.